Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and Escherichia coli Infections

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Escherichia coli Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gromov, MS; Maslyakov, VV; Zabrodskii, PF1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Escherichia coli Infections

ArticleYear
Combined Effects of M1 Muscarinic Acetylcholine Receptor Agonist TBPB and α7n-Acetylcholine Receptor Activator GTS-21 on Mouse Mortality and Blood Concentration of Proinflammatory Cytokines in Sepsis.
    Bulletin of experimental biology and medicine, 2017, Volume: 162, Issue:6

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzimidazoles; Benzylidene Compounds; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation; Interleukin-1beta; Interleukin-6; Male; Mice; Muscarinic Agonists; Nicotinic Agonists; Piperidines; Pyridines; Receptor, Muscarinic M1; Sepsis; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha

2017